Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
17 April 2023 - P2271
Desirability of outcome ranking (DOOR): application to a phase 3 registrational trial evaluating sulopenem for patients with uncomplicated urinary tract infection (uUTI)
Steven Aronin, Jayanti Gupta, Michael Dunne, Sailaja Puttagunta
17 April 2023 - P2255
Desirability of outcome ranking (DOOR): application to a phase 3 registrational trial evaluating sulopenem for patients with complicated urinary tract infection (cUTI)
Sailaja Puttagunta, Jayanti Gupta, Michael Dunne, Steven Aronin
23 April 2022 - P1398
Efficacy and safety of intravenous sulopenem followed by oral sulopenem etzadroxil/probenecid versus intravenous ertapenem followed by oral ciprofloxacin and metronidazole or amoxicillin-clavulanate in the treatment of complicated intra-abdominal infectio
Steven Aronin, Jeanne Breen, Michael Dunne, Sailaja Puttagunta
23 April 2022 - P1302
In vitro activity of sulopenem and comparator agents against anaerobic clinical isolates from the SENTRY surveillance programme 2018-2020
Steven Aronin, Sailaja Puttagunta, Michael Dunne, Chris Blankers, Joshua Maher, Michael Huband
15 April 2019 - P1705
In vitro activity of sulopenem against resistant Neisseria gonorrhoeae
Michael Dunne, Sailaja Puttagunta, Jeanna DiFranco-Fisher, Laura Koeth
15 April 2019 - P1992
Post-antibiotic and sub-inhibitory minimum inhibitory concentration effects of sulopenem
Michael Dunne, Sailaja Puttagunta, Steven Aronin, Michael Huband, Robert Flamm
15 April 2019 - P1656
A patient-specific clinical predictive model to anticipate the risk of treatment failure in uncomplicated urinary tract infections
Michael Dunne, Sailaja Puttagunta, Stephen Brossette, John Murray, Pat Hymel, Vikas Gupta
23 April 2018 - O0736
Impact of initial inappropriate antibiotic therapy on the outcome of uncomplicated urinary tract infection due to antibiotic non-susceptible Enterobacteriaceae
Sailaja Puttagunta, S. Puttagunta, S. Aronin, V. Gupta, J. Murray, M. Dunne
25 April 2017 - P2126
Outcomes in patients with Staphylococcus aureus bacteraemia treated with dalbavancin in clinical trials
Pedro Gonzalez, Urania Rappo, Karthik Akinapelli, Jennifer S. McGregor, Sailaja Puttagunta, Michael Dunne
22 April 2017 - EP0176
Safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSI): nephrotoxicity rates compared to vancomycin
Sara Jonsson, Pedro Gonzalez, Urania Rappo, Karthik Akinapelli, Jennifer S. McGregor, Sailaja Puttagunta, Michael Dunne
22 April 2017 - P0510
Five-year observation after CRE introduction in a high-complexity hospital: what have we learned about surveillance, outbreaks and molecular epidemiology?
Sailaja Puttagunta, Cely Abboud, Juliane Mello, Jussimara Monteiro, Ercilia Souza, Vera Lucia Barbosa, Antônio Pignatari, Carlos Kiffer
22 April 2017 - OS0130
Dalbavancin for the treatment of osteomyelitis in adult patients
Sara Jonsson, Alena Jandourek, Vadym Shevchenko, Olena Shevchenko, Urania Rappo, Pedro Gonzalez, Sailaja Puttagunta, Michael Dunne, Rosa Miceli, Milan Kovacevic, Gertjan De Bock
26 April 2015 - P0705
Dalbavancin for the treatment of acute bacterial skin and skin structure infections in obese patients
Sailaja Puttagunta, Puttagunta, Sailaja *; Dunne, Michael;
13 May 2014 - P1818
Geographic differences in the presentation and outcomes of acute bacterial skin and skin structure infections (ABSSSI) in the DISCOVER program
Sailaja Puttagunta, Puttagunta, S.(1)*; Talbot, G.(2); Wilcox, M.(3); Boucher, H.(4); Dunne, M.(1);
13 May 2014 - P1819
Clinical presentation and outcomes by subtype of infection in patients with acute bacterial skin and skin structure infections (ABSSSI) in the DISCOVER program
Sailaja Puttagunta, Puttagunta, S.(1)*; Talbot, G.(2); Wilcox, M.(3); Boucher, H.(4); Dunne, M.(1);
13 May 2014 - P1820
Clinical presentation of acute bacterial skin and skin structure infections (ABSSSI) by baseline pathogen in the DISCOVER program
Sailaja Puttagunta, Puttagunta, S.(1)*; Talbot, G.(2); Wilcox, M.(3); Boucher, H.(4); Dunne, M.(1);
10 May 2014 - eP409
Dalbavancin for the treatment of complicated skin and soft tissue infections in patients with and without diabetes mellitus in the DISCOVER studies
Sailaja Puttagunta, Puttagunta, S.(1)*; Dunne, M.(1);
10 May 2014 - eP408
Treatment of acute bacterial skin and skin structure infection (ABSSSI) with dalbavancin in an outpatient setting
Sailaja Puttagunta, Dunne, M.(1)*; Puttagunta, S.(1); Wilcox, M.(2); Boucher, H.(3); Talbot, G.(4);
10 May 2014 - P0193
Are Staphylococcus aureus PVL toxin-positive isolates causing acute bacterial skin and skin structure infections (ABSSSI) associated with more severe presentation or worse outcome?
Sailaja Puttagunta, Puttagunta, S.(1)*; Boucher, H.(2); Wilcox, M.(3); Talbot, G.(4); Dunne, M.(1);
27 April 2013 - P1007
Cryptococcus neoformans: an emerging pathogen in critical hosts?
Sailaja Puttagunta, A. Oliveira*, J. Silva, V. Barbosa, D. Cortez, E. Souza, E. Zandonadi, C. Abboud (São Paulo, BR)
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.